Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population
Open Access
- 1 January 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 5 (1) , 73-80
Abstract
Hypertrophic cardiomyopathy (HCM) is a common genetic heart disease with a population prevalence ratio of approximately 1:500.1 Early HCM cohort studies reported a high mortality due to sudden cardiac death (SCD) and heart failure but were limited by a significant selection bias.2 Contemporary survival studies have shown that the prognosis for most individuals with the disease may be better than described previously, particularly when it is managed in line with current clinical practice guidelines,3 but the excess mortality that HCM conveys when compared with the general population remains unclear.4,5 We sought to compare the survival of patients with HCM in a large multicenter European cohort with that observed in the general population using contemporaneous country, age-stratified, and sex-stratified European mortality data.Keywords
This publication has 25 references indexed in Scilit:
- Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health recordsPLOS ONE, 2018
- Perspectives on the Overall Risks of Living With Hypertrophic CardiomyopathyCirculation, 2017
- Predictors of atrial fibrillation in hypertrophic cardiomyopathyHeart, 2016
- Prediction of Thrombo-Embolic Risk in Patients with Hypertrophic Cardiomyopathy (HCM Risk-CVA)European Journal of Heart Failure, 2015
- New Perspectives on the Prevalence of Hypertrophic CardiomyopathyJACC, 2015
- World Medical Association Declaration of HelsinkiJAMA, 2013
- A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)European Heart Journal, 2013
- Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of AgeCirculation, 2013
- Historical trends in reported survival rates in patients with hypertrophic cardiomyopathyHeart, 2005
- Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.Heart, 1997